LUPIN
Lupin Ltd.
Latest scanner signal, chart levels and stage timeline for LUPIN. Research only, not advice.
Copied
Latest status
Pre-Breakout
Weak
Scan date 2026-05-11
₹2244.9
Latest price
10.0
Latest scanner score
14
Saved appearances
large_mid
Healthcare
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Daily Chart
Levels are generated from the latest scanner row.
Results & Fundamentals Lens
Compounding growth
Latest quarterly snapshot saved for LUPIN. Use it with price action, not as standalone advice.
Acceleration
Strong
Quarter ended 2025-12-31
Revenue YoY
Top-line growth vs same quarter last year
+29.2%
Revenue QoQ
Sequential sales momentum
+15.2%
EPS YoY
Profit growth vs same quarter last year
+37.7%
EPS QoQ
Sequential earnings momentum
-3.6%
Event Radar
2026-08-05
86 days until next reported result date.
Fundamentals fetched2026-05-08
Calendar fetched2026-05-11
What to notice
Revenue and EPS are growing at a pace that usually supports sustained relative strength when price confirms.
YoY and QoQ deltas benchmark the latest reported quarter ending 2025-12-31.
Detailed Scanner Breakdown
Detailed fields from the latest pre-breakout row.
Weak · 10.0
Price
₹2244.9
Stage
Unknown
RS trend
–
Sector RS
0.0%
Base
–
Base quality
–
Vol quality
–
Failure risk
–
RS rank
–
RSI
42.3
ADX
11.6
Avg value
–
Distribution
0 day(s)
VCP
–
Vol dry
No
Flags
None
Scanner Notes
✓ SKIP: Price below 50DMA (2244.90 <= 2317.11)
Related Stocks
Same sector or industry, ranked by latest pre-breakout score.
NATCOPHARM
NATCO Pharma Ltd.
Very Strong
88.9
TORNTPHARM
Torrent Pharmaceuticals Ltd.
Very Strong
84.3
STAR
Strides Pharma Science Ltd.
Very Strong
82.8
LAURUSLABS
Laurus Labs Ltd.
Very Strong
81.9
YATHARTH
Yatharth Hospital & Trauma Care Services Ltd.
Very Strong
81.2
AUROPHARMA
Aurobindo Pharma Ltd.
Strong
79.2
ASTERDM
Aster DM Healthcare Ltd.
Strong
78.5
GLENMARK
Glenmark Pharmaceuticals Ltd.
Strong
75.8